Effects of Hypertension on Alzheimer's Disease and Related Disorders

Joseph E Malone1, Mohamed I Elkasaby1, Alan J Lerner2,3

  • 1Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Current Hypertension Reports
|September 20, 2022
PubMed

Insights

High blood pressure (hypertension) contributes to cognitive decline. Treating hypertension with various medications shows promise for improving cognition in dementia patients, though no single drug is superior.

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • Hypertension is a significant risk factor for neurodegenerative dementias, including Alzheimer's disease.
  • Cognitive impairment is increasingly linked to elevated blood pressure levels.
  • The renin-angiotensin-aldosterone system is implicated in both hypertension and cognitive decline.

Purpose of the Study:

  • To review the pathophysiology of hypertension in Alzheimer's disease and related dementias.
  • To explore clinical trials investigating hypertension treatment for cognitive improvement.

Main Methods:

  • Literature review of pathophysiology and clinical trial data.
  • Analysis of studies evaluating antihypertensive agents and their cognitive outcomes.

Main Results:

  • Clinical trials suggest blood pressure reduction via antihypertensives can improve cognition.
  • Various antihypertensive classes have been studied, with interest in renin-angiotensin-aldosterone system inhibitors.
  • No specific antihypertensive agent has demonstrated superiority in reducing dementia risk or providing neuroprotection.

Conclusions:

  • Hypertension is a modifiable risk factor for dementia.
  • Antihypertensive therapy generally shows favorable outcomes for cognitive function in dementia patients.
  • Further research is needed to identify optimal treatment strategies for hypertension in dementia.
Abstract

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
640
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
249
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
56
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
41
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.3K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
56